EN
Select language

News

Bracco Imaging acquires SurgVision expanding into the innovative field of fluorescence imaging-guided surgery

Milan, Italy , 10/18/2017

Bracco Imaging S.p.A today announced the acquisition of SurgVision, a high-tech start-up focused on developing a real-time Fluorescence Image Guided Surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

As surgery remains the primary curative option for most solid cancers, a predominant challenge for surgeons during these procedures has been the limitations of visual inspection and digital palpation to distinguish tumors from healthy tissue. Fluorescence Image Guided Surgery represents an innovative intra-operative optical technique aimed at assisting surgeons in distinguishing tumors from surrounding tissue, using a combined infrared camera and contrast agent approach. In this context, SurgVision’s innovative targeting solution is expected to provide significant improvements versus competing modalities and products, due to the extremely advanced features of its optical camera and the very sensitive targeting performance of its new imaging agent.

With the acquisition of SurgVision, one of the most advanced companies in a very promising field, we intend to address a relevant, unmet medical need for oncology patients who have to undergo tumor removal surgery” said Fulvio Renoldi Bracco, Chief Executive Officer at Bracco Imaging. “SurgVision platform expands our imaging solutions for healthcare professionals in oncology and reinforces our long-lasting commitment to patient care” he concluded.

The investment in Surgvision provides Bracco Imaging with key competencies and technologies strategically adjacent to our core business” said Micol Fornaroli, Chief Strategy Officer at Bracco Imaging “and, at the same time, will accelerate the development of the projects currently in scope of our Research and Development efforts.”

The acquisition of SurgVision by Bracco is a vote of confidence for the field of fluorescence image-guided surgery and for the achievements so far by the SurgVision team” said Ton van den Hoven, Chief Executive Officer at SurgVision. “The expertise and commitment from Bracco will allow SurgVision to continue developing a solution that delivers on the potential of important clinical benefits for patients.”

Bracco WorldWide

The Bracco Group,
through its subsidiary
Bracco Imaging
operates throughout
the world both directly
or indirectly.

Read more

Our History

The Bracco Group
exists since 1927,
when Elio Bracco
founded the Italian
E. Merck company
branch.

Read more

Structure

The Bracco Group
operates through its
three business units.

Read more